Gene-Environment Interactions: My Unique Journey

Annu Rev Pharmacol Toxicol. 2024 Jan 23:64:1-26. doi: 10.1146/annurev-pharmtox-022323-082311. Epub 2023 Oct 3.

Abstract

I am deeply honored to be invited to write this scientific autobiography. As a physician-scientist, pediatrician, molecular biologist, and geneticist, I have authored/coauthored more than 600 publications in the fields of clinical medicine, biochemistry, biophysics, pharmacology, drug metabolism, toxicology, molecular biology, cancer, standardized gene nomenclature, developmental toxicology and teratogenesis, mouse genetics, human genetics, and evolutionary genomics. Looking back, I think my career can be divided into four distinct research areas, which I summarize mostly chronologically in this article: (a) discovery and characterization of the AHR/CYP1 axis, (b) pharmacogenomics and genetic prediction of response to drugs and other environmental toxicants, (c) standardized drug-metabolizing gene nomenclature based on evolutionary divergence, and (d) discovery and characterization of the SLC39A8 gene encoding the ZIP8 metal cation influx transporter. Collectively, all four topics embrace gene-environment interactions, hence the title of my autobiography.

Keywords: AHR transcription factor; AHR-CYP1A1 axis; Slc39a8 gene encoding ZIP8 metal cation influx transporter; aryl hydrocarbon hydroxylase; aryl hydrocarbon receptor; autobiography; genetic differences in drug (or other environmental toxicant) response; pharmacogenetics; standardized gene nomenclature.

Publication types

  • Review

MeSH terms

  • Animals
  • Genomics*
  • Humans
  • Membrane Transport Proteins
  • Mice
  • Pharmacogenetics
  • Physicians*

Substances

  • Membrane Transport Proteins